Stock LAVI LAVIPHARM S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Charts Lavipharm S.A.

Equities

LAVI

GRS246003008

Delayed Athens S.E.
Other stock markets
 10:19:23 2024-05-14 EDT 		5-day change 1st Jan Change
0.895 EUR +0.56% Intraday chart for Lavipharm S.A. +5.54% +12.44%
02-28 Lavipharm S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Lavipharm S.A. entered into a new asset purchase agreement to acquire Flagyl product line for Greek market from Sanofi. CI

Chart: Technical Analysis

Technical analysis trends

Short TermMid-TermLong Term
Trend

Bullish

Bullish

Bullish

Resistance 0.9280 0.9500 0.9400
Spread/Res.-3.56%-5.79%-4.79%
Spread/Supp.+5.54%+14.45%+17.76%
Support 0.8480 0.7820 0.7600
  1. Stock Market
  2. Equities
  3. LAVI Stock
  4. Charts Lavipharm S.A.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW